Abstract: The invention relates to a computer-implemented method for determining the stability of a substance or substance mixture. According to an embodiment, the method comprises the following steps: a data acquisition step in which at least one measurement data record is received, every measurement data record representing a chemical, in particular photochemical profile of the substance or substance mixture in question; a data evaluation step which comprises for each measurement data record: determining an initial value of the material or material mix in question on the basis of the measurement data record; and quantifying the change of the material or material mix in question in relation to the initial value by means of a mathematical distance value; and a data output step in which the change of the material or material mix in question is graphically represented for every measurement data record.

Abstract: The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.

Abstract: The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.

Abstract: The invention relates to a hydrolyzate from at least one extract of at least one plant material selected from the group consisting of at least one genus: Equiseti, Juglandis, Millefolii, Quercus, Taraxaci, Althaeae, Matricariae, Centaurium, Levisticum, Rosmarinus, Angelica(e), Artemisia, Astragalus, Leonurus, Salvia, Saposhnikovia, Scutellaria, Siegesbeckia, Armoracia, Capsicum, Cistus, Echinacea, Echinacea, Galphimia, Hedera, Melia, Olea, Pelargonium, Phytolacca, Primula, Salix, Thymus, Vitex, and Vitis; and to a mixture thereof and to a method of production and the use thereof. The invention further relates to an agent and drug obtainable on the basis of the hydrolyzate.

Abstract: The invention relates to a method for producing dry extracts of plants and to pharmaceutical preparations containing the same, more particularly phytopharmaceuticals, which contain at least one ethanolic/aqueous extract of a plant (drug), the plants being selected from the group consisting of: Rumicis herba; Verbena officinalis; Sambucus nigra; Primula veris; and Gentiana lutea and mixtures thereof. The invention further relates to a pharmaceutical for treating inflammatory and/or infectious diseases of the nose and throat area and/or the nasal sinuses, as well as the use thereof.

Abstract: The present invention relates to an antibacterial agent and a hydrolysate made of at least one extract that has been produced by extraction using ethanol/water from dried plant material of: a) at least one of the plants selected from the group consisting of: Verbena officinalis L., Sambucus nigra L., Primula veris L., Primula elatior (L.) Hill, and Gentiana lutea L.; and a mixture thereof; or b) a mixture of: Verbena officinalis L., Sambucus nigra L., Primula veris L., Gentiana lutea L., and Rumicis herba; and subsequent removal of the ethanol/water extraction agent, wherein the hydrolysate can be obtained from the extract via hydrolytic treatment using a mineral acid. The hydrolyzates according to the invention show a pronounced antibacterial effect against germs relevant to the skin, ears, nose, and throat and respiratory systems.

Abstract: The invention relates to an extract made of thyme (Thymus L.) in combination with primrose (Primula veris) or ivy (Hedera helix) for the prophylaxis and treatment of chronic obstructive pulmonary diseases (COPD) and to a corresponding medicinal product and the use thereof.

Abstract: The invention relates to a detergent, cleaning agent or disinfectant containing at least one plant hydrolyzate, in particular selected from the group including Althaeae radix (marshmallow root), Angelica(e) dahurica (dahurian angelica), Angelica(e) sinensis (Chinese angelica), Armoracia rusticana (horseradish), Artemisia scoparia (redstem wormwood), Astragalus membranaceus (var. mongolicus) (Chinese milk vetch), Capsicum sp., Capsicum annuum (pepper), Centaurium erythraea (common centaury), Cistus incanus (hairy rockrose), Echinacea angustifolia (narrow-leaved purple coneflower), Echinacea purpurea (eastern purple coneflower), Equiseti herba (horsetail), Galphimia glauca, Gentiana lutea L.

Abstract: The invention relates to a cosmetic or dermatological composition or a means for body care and beauty care, preferably on a pure plant basis, for topical use, containing at least one plant hydrolyzate, in particular selected from the group Althaeae radix (marshmallow root), Angelica(e) dahurica (dahurian angelica), Angelica(e) sinensis (Chinese angelica), Armoracia rusticana (horseradish), Artemisia scoparia (redstem wormwood), Astragalus membranaceus (var. mongolicus) (Chinese milk vetch), Capsicum sp., Capsicum annuum (pepper), Centaurium erythraea (common centaury), Cistus incanus (hairy rockrose), Echinacea angustifolia (narrow-leaved purple coneflower), Echinacea purpurea (eastern purple coneflower), Equiseti herba (horsetail), Galphimia glauca, Gentiana lutea L.

Abstract: The invention relates to a hydrolyzate from at least one extract of at least one plant material selected from the group consisting of at least one genus: Equiseti, Juglandis, Millefolii, Quercus, Taraxaci, Althaeae, Matricariae, Centaurium, Levisticum, Rosmarinus, Angelica(e), Artemisia, Astragalus, Leonurus, Salvia, Saposhnikovia, Scutellaria, Siegesbeckia, Armoracia, Capsicum, Cistus, Echinacea, Echinacea, Galphimia, Hedera, Melia, Olea, Pelargonium, Phytolacca, Primula, Salix, Thymus, Vitex, and Vitis; and to a mixture thereof and to a method of production and the use thereof. The invention further relates to an agent and drug obtainable on the basis of the hydrolyzate.

Abstract: The present invention relates to an antibacterial agent and a hydrolysate made of at least one extract that has been produced by extraction using ethanol/water from dried plant material of: a) at least one of the plants selected from the group consisting of: Verbena officinalis L., Sambucus nigra L., Primula veris L., Primula elatior (L.) Hill, and Gentiana lutea L.; and a mixture thereof; or b) a mixture of: Verbena officinalis L., Sambucus nigra L., Primula veris L., Gentiana lutea L., and Rumicis herba; and subsequent removal of the ethanol/water extraction agent, wherein the hydrolysate can be obtained from the extract via hydrolytic treatment using a mineral acid. The hydrolyzates according to the invention show a pronounced antibacterial effect against germs relevant to the skin, ears, nose, and throat and respiratory systems.